VPPIPP and IPPVPP: two hexapeptides innovated to exert antihypertensive activity.
In this study, two hexapeptides of IPPVPP and VPPIPP were innovated by using two commercial antihypertensive peptides IPP and VPP as two domains cis-linked and trans-linked, respectively. The IPPVPP and VPPIPP were chemically synthesized and evaluated for the antihypertensive activity in vitro/vivo....
Guardado en:
Autores principales: | Fengyun Ding, Bingjun Qian, Xin Zhao, Shanqi Shen, Yun Deng, Danfeng Wang, Feng Zhang, Zhongquan Sui, Pu Jing |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cbaf812779844977bdd1166618597d7d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue
por: Zhang X, et al.
Publicado: (2017) -
Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes
por: Darja Kanduc
Publicado: (2010) -
Defined d-hexapeptides bind CUG repeats and rescue phenotypes of myotonic dystrophy myotubes in a Drosophila model of the disease
por: Anna Rapisarda, et al.
Publicado: (2021) -
Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy
por: Tatiana Yu. Demidova, et al.
Publicado: (2021) -
Antihypertensive drug prescription trends in Shahrekord, Iran
por: Ahmadreza Maghsoudi, et al.
Publicado: (2022)